ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI)

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

November 30, 2013

Conditions
Symptomatic Aortic Stenosis
Interventions
DEVICE

ACURATE TA™ Transapical Aortic Bioprosthesis

ACURATE TA™ Transapical Aortic Bioprosthesis is intended for subjects with severe symptomatic aortic stenosis and are considered high risk for surgical conventional Aortic Valve Replacement.

Trial Locations (17)

3010

Inselspital-Stiftung, Bern

4190

Hospital Italiano de Buenos Aires, Buenos Aires

20251

Universitäres Herzzentrum, Hamburg

40138

Policlinico s. Orsola-Malpighi, Bologna

45122

Klinik für Tgorax und Gefässchirurgie, Essen

49214

Schüchtermann-Schiller'sche Kliniken GmbH, Bad Rothenfelde

50937

Uniklinik Köln Herzzentrum, Cologne

52074

RWTH Aachen, Aachen

55131

Universitäts Medizin Mainz, Mainz

61231

Kerckhoff Klinik Bad Nauheim, Bad Nauheim

70174

Sana Herzchirurgie Stuttgart GmbH, Stuttgart

76185

Klinik für Herzchirurgie, Karlsruhe

93053

Universitätsklinikum Regensburg, Regensburg

97616

Herz-und Gefäss-Klinik GmbH, Bad Neustadt an der Saale

99437

Zentralklinik Bad Berka, Bad Berka

01307

Herzzentrum Dresden Universitätsklinik, Dresden

04289

Herzzentrum Leipzig, Leipzig

All Listed Sponsors
lead

Symetis SA

INDUSTRY

NCT03143686 - ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI) | Biotech Hunter | Biotech Hunter